Brain Advance Access published online on January 11, 2005
Brain, doi:10.1093/brain/awh368
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 ZMMK and Institute for Genetics, University of Cologne, Cologne, Germany
* To whom correspondence should be addressed. Summary Axonal dystrophy is the hallmark of axon pathology in many neurodegenerative disorders of the CNS, including Alzheimer's disease, Parkinson's disease and stroke. Axons can also form larger swellings, or spheroids, as in multiple sclerosis and traumatic brain injury. Some spheroids are terminal endbulbs of axon stumps, but swellings may also occur on unbroken axons and their role in axon loss remains uncertain. Similarly, it is not known whether spheroids and axonal dystrophy in so many different CNS disorders arise by a common mechanism. These surprising gaps in current knowledge result largely from the lack of experimental methods to manipulate axon pathology. The slow Wallerian degeneration gene, WldS, delays Wallerian degeneration after injury, and also delays dying-back in peripheral nervous system disorders, revealing a mechanistic link between two forms of axon degeneration traditionally considered distinct. We now report that WldS also inhibits axonal spheroid pathology in gracile axonal dystrophy (gad) mice. Both gracile nucleus (P < 0.001) and cervical gracile fascicle (P = 0.001) contained significantly fewer spheroids in gad/WldS mice, and secondary signs of axon pathology such as myelin loss were also reduced. Motor nerve terminals at neuromuscular junctions continued to degenerate in gad/WldS mice, consistent with previous observations that WldS has a weaker effect on synapses than on axons, and probably contributing to the fact that WldS did not alleviate gad symptoms. WldS acts downstream of the initial pathogenic events to block gad pathology, suggesting that its effect on axonal swelling need not be specific to this disease. We conclude that axon degeneration mechanisms are more closely related than previously thought and that a link exists in gad between spheroid pathology and Wallerian degeneration that could hold for other disorders.
Received April 17, 2004
Revised August 12, 2004
Accepted November 1, 2004
Article
The slow Wallerian degeneration gene, WldS, inhibits axonal spheroid pathology in gracile axonal dystrophy mice
2 ZMMK and Institute for Genetics, University of Cologne, Cologne, Germany; Department of Anatomy I, University of Cologne, Cologne, Germany
3 Division of Neuroscience, University of Edinburgh, Edinburgh, UK
4 ZMMK and Institute for Genetics, University of Cologne, Cologne, Germany; The Babraham Institute, Babraham, Cambridge, UK
5 Department of Degenerative Neurological Diseases, National Institute of Neuroscience, Kodaira, Tokyo, Japan; Clinical Research Institute, Kanagawa Children's Medical Center, Yokohama, Japan
6 The Babraham Institute, Babraham, Cambridge, UK
7 Department of Anatomy I, University of Cologne, Cologne, Germany
8 Department of Degenerative Neurological Diseases, National Institute of Neuroscience, Kodaira, Tokyo, Japan
Michael P. Coleman, E-mail: michael.coleman{at}bbsrc.ac.uk
![]()
Abstract ![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
B. Beirowski, E. Babetto, J. Gilley, F. Mazzola, L. Conforti, L. Janeckova, G. Magni, R. R. Ribchester, and M. P. Coleman Non-Nuclear WldS Determines Its Neuroprotective Efficacy for Axons and Synapses In Vivo J. Neurosci., January 21, 2009; 29(3): 653 - 668. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Press and J. Milbrandt Nmnat Delays Axonal Degeneration Caused by Mitochondrial and Oxidative Stress J. Neurosci., May 7, 2008; 28(19): 4861 - 4871. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. R. Howell, R. T. Libby, T. C. Jakobs, R. S. Smith, F. C. Phalan, J. W. Barter, J. M. Barbay, J. K. Marchant, N. Mahesh, V. Porciatti, et al. Axons of retinal ganglion cells are insulted in the optic nerve early in DBA/2J glaucoma J. Cell Biol., December 31, 2007; 179(7): 1523 - 1537. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Wishart, J. M. Paterson, D. M. Short, S. Meredith, K. A. Robertson, C. Sutherland, M. A. Cousin, M. B. Dutia, and T. H. Gillingwater Differential Proteomics Analysis of Synaptic Proteins Identifies Potential Cellular Targets and Protein Mediators of Synaptic Neuroprotection Conferred by the Slow Wallerian Degeneration (Wlds) Gene Mol. Cell. Proteomics, August 1, 2007; 6(8): 1318 - 1330. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. H. Gillingwater, C. A. Ingham, K. E. Parry, A. K. Wright, J. E. Haley, T. M. Wishart, G. W. Arbuthnott, and R. R. Ribchester Delayed synaptic degeneration in the CNS of Wlds mice after cortical lesion Brain, June 1, 2006; 129(6): 1546 - 1556. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Pernet and A. Di Polo Synergistic action of brain-derived neurotrophic factor and lens injury promotes retinal ganglion cell survival, but leads to optic nerve dystrophy in vivo Brain, April 1, 2006; 129(4): 1014 - 1026. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Laser, L. Conforti, G. Morreale, T. G.M. Mack, M. Heyer, J. E. Haley, T. M. Wishart, B. Beirowski, S. A. Walker, G. Haase, et al. The Slow Wallerian Degeneration Protein, WldS, Binds Directly to VCP/p97 and Partially Redistributes It within the Nucleus Mol. Biol. Cell, March 1, 2006; 17(3): 1075 - 1084. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. H. Gillingwater, T. M. Wishart, P. E. Chen, J. E. Haley, K. Robertson, S. H.-F. MacDonald, S. Middleton, K. Wawrowski, M. J. Shipston, S. Melmed, et al. The neuroprotective WldS gene regulates expression of PTTG1 and erythroid differentiation regulator 1-like gene in mice and human cells Hum. Mol. Genet., February 15, 2006; 15(4): 625 - 635. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Kaneko-Oshikawa, T. Nakagawa, M. Yamada, H. Yoshikawa, M. Matsumoto, M. Yada, S. Hatakeyama, K. Nakayama, and K. I. Nakayama Mammalian E4 Is Required for Cardiac Development and Maintenance of the Nervous System Mol. Cell. Biol., December 15, 2005; 25(24): 10953 - 10964. [Abstract] [Full Text] [PDF] |
||||






